Go to www.sensodetect.se

Employment of Chief Scientific Officer

Jens Holmberg is a well-reputed senior scientist with a track record that involves both high-impact journals and patents. Jens has a PhD from Lund University in Medical Science and two Master degrees in Chemistry and Biomedicine. During the last 7 years, Jens has had key positions in research at various industries (Director Immunology at Bionor Immuno AS/Norway; Principal Investigator at Pharmexa AS/Denmark; Technology Team Leader at Pharmexa-Epimmune/San-Diego) were he has implemented several successful proof-of-concept studies. Jens has hands-on experience for several disease areas (Rheumatoid Arthritis, Multiple Sclerosis, Alzheimer´s Disease, Cancer, Osteoporosis, HIV, HCV, FLU) and along with his strong academic inclination, statistical support and pleasant personality, he will be a valuable asset to the corporation.
 


For more information:
Johan Källstrand, CEO SensoDetect AB

Phone: + 46 (0) 736-770088
E-mail: johan.kallstrand(snabel-a)sensodetect(punkt)com
SensoDetect has developed a method for objective neurophysiological decision support for diagnostics, primarily in psychiatric health care and forensics. The technology underlying SensoDetect’s test instrument, SensoDetect® BERA, is based on brainstem audiometry and is the result of extensive research at Lund University.